EIKN vs LTGO: fair value comparison
Eikon Therapeutics, Inc. and Latigo Biotherapeutics, Inc. · Updated 2026-10-19
EIKN has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. LTGO has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, EIKN currently ranks higher by quality score.
| EIKN | LTGO | |
|---|---|---|
| Verdict | No estimate yet | No estimate yet |
| Last price | $7.42 | $14.00 |
| 12-month range | $7.41–$15.00 | $14.00–$22.26 |
| Rank by discount to fair value | — | — |
| Rank by quality score | #287 of 301 Healthcare | #288 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | Low |
| RSI zone | Neutral | Oversold |
| 52-week position | The bottom quarter | The bottom quarter |
Full single-stock breakdowns: EIKN fair value analysis · LTGO fair value analysis